Graham Radford-Smith

Graham Radford-Smith

UNVERIFIED PROFILE

Are you Graham Radford-Smith?   Register this Author

Register author
Graham Radford-Smith

Graham Radford-Smith

Publications by authors named "Graham Radford-Smith"

Are you Graham Radford-Smith?   Register this Author

74Publications

2233Reads

37Profile Views

Crohn's disease is facilitated by a disturbance of programmed death-1 ligand 2 on blood dendritic cells.

Clin Transl Immunology 2019 25;8(7):e01071. Epub 2019 Jul 25.

Molecular Immunology Laboratory QIMR Berghofer Medical Research Institute Herston QLD Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cti2.1071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657371PMC
July 2019

Food avoidance in outpatients with Inflammatory Bowel Disease - Who, what and why.

Clin Nutr ESPEN 2019 Jun 9;31:10-16. Epub 2019 Apr 9.

The University of Queensland, Brisbane, Australia; QIMR Berghofer Medical Research Institute, Brisbane, Australia; Department of Gastroenterology and Hepatology, Royal Brisbane and Women's Hospital, Brisbane, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clnesp.2019.03.018DOI Listing
June 2019

Detectable Laboratory Abnormality Is Present up to 12 Months Prior to Diagnosis in Patients with Crohn's Disease.

Dig Dis Sci 2019 02 26;64(2):503-517. Epub 2018 Nov 26.

Inflammatory Bowel Diseases Research Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-018-5357-0DOI Listing
February 2019

Evaluating a risk assessment tool to improve triaging of patients to colonoscopies.

Intern Med J 2019 Feb 28. Epub 2019 Feb 28.

QIMR Berghofer Medical Research Institute, Population Health Department, Herston, Brisbane Q4006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.14267DOI Listing
February 2019

The effect of pre-admission immunosuppression on colectomy rates in acute severe ulcerative colitis.

Therap Adv Gastroenterol 2018 13;11:1756284818809789. Epub 2018 Nov 13.

Department of Gastroenterology and Hepatology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756284818809789DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236856PMC
November 2018

Predicting response after infliximab salvage in acute severe ulcerative colitis.

J Gastroenterol Hepatol 2018 Jul 27;33(7):1347-1352. Epub 2018 Feb 27.

Department of Gastroenterology, Austin Health, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14072DOI Listing
July 2018

A rolling phenotype in Crohn's disease.

PLoS One 2017 6;12(4):e0174954. Epub 2017 Apr 6.

Inflammatory Bowel Diseases Research Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0174954PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383106PMC
September 2017

Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis.

Clin Gastroenterol Hepatol 2017 Aug 7;15(8):1248-1255. Epub 2017 Mar 7.

Department of Gastroenterology and Hepatology, Liverpool Hospital, Sydney, NSW, Australia; South Western Sydney Clinical School, University of NSW Medicine, Sydney, NSW, Australia; Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, UNSW Australia, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2017.02.027DOI Listing
August 2017

Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.

World J Gastroenterol 2016 Nov;22(41):9104-9116

Angela C Baird, Ian C Lawrance, Faculty of Medicine and Dentistry, School of Medicine and Pharmacology, University of Western Australia, Perth, WA 6009, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v22.i41.9104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107592PMC
November 2016

High Vitamin D-Binding Protein Concentration, Low Albumin, and Mode of Remission Predict Relapse in Crohn's Disease.

Inflamm Bowel Dis 2016 10;22(10):2456-64

*Harry Perkins Institute of Medical Research, School of Medicine and Pharmacology, University of Western Australia, Murdoch, Western Australia, Australia;†Telethon Kids Institute, University of Western Australia, Subiaco, Western Australia, Australia;‡UWA Centre for Applied Statistics, University of Western Australia, Western Australia, Crawley, Australia;§Department of Gastroenterology and Hepatology, Flinders Medical Centre, South Australia, Adelaide, Australia;‖Department of Gastroenterology and Hepatology, Royal Brisbane and Women's Hospital, Queensland, Brisbane, Australia; and¶Centre for Inflammatory Bowel Diseases, Saint John of God Hospital, Subiaco, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000894DOI Listing
October 2016

Altered Expression of Angiotensinogen and Mediators of Angiogenesis in Ileal Crohn's Disease.

J Gastrointestin Liver Dis 2016 Mar;25(1):39-48

QIMR Berghofer Medical Research Institute and University of Queensland School of Medicine, Herston Campus;Department of Gastroenterology, Royal Brisbane and Women's Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15403/jgld.2014.1121.251.chrDOI Listing
March 2016

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.

Nat Genet 2015 Sep 3;47(9):987-995. Epub 2015 Aug 3.

Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3373DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557485PMC
September 2015

Response to Magro et al.

Am J Gastroenterol 2015 Jun;110(6):931-2

1] Inflammatoy Bowel Diseases Research Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia [2] Department of Gastroenterology and Hepatology, Royal Brisbane and Women's Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2015.131DOI Listing
June 2015

Smoking behaviour modifies IL23r-associated disease risk in patients with Crohn's disease.

J Gastroenterol Hepatol 2015 Feb;30(2):299-307

CSIRO Computational Informatics/Australian E-Health Research Centre, Royal Brisbane and Women's Hospital, Brisbane, Victoria, Australia; Preventative Health Flagship, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.12674DOI Listing
February 2015

The effect on melanoma risk of genes previously associated with telomere length.

J Natl Cancer Inst 2014 Oct 17;106(10). Epub 2014 Sep 17.

Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds, Leeds, UK (MMI, DTB, JCT, MHa, JRM, JANB, JHB); Oncogenomics (NKH), Genetic Epidemiology (NGM), Inflammatory Bowel Diseases Laboratory (GLRS), Cancer Control Group (DCW), Statistical Genetics (SM, MHL), and Molecular Epidemiology (GWM), QIMR Berghofer Medical Research Institute, Brisbane, Australia; INSERM, UMR-946, Genetic Variation and Human Diseases Unit, Paris, France (MB, FD); Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France (MB, FD); Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Australia (AEC); Department of Oncology, University of Cambridge, Cambridge, UK (AMD, PDPP); Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX (JEL); Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Crawley, Australia (EKM, SVW); Centre for Cancer Biomarkers CCBIO (LAA) and Gade Laboratory for Pathology (AM), Department of Clinical Medicine, University of Bergen, Bergen, Norway; Department of Pathology, Haukeland University Hospital, Bergen, Norway (LAA); Department of Pathology, Molecular Pathology (PAA) and Department of Dermatology (PH), Oslo University Hospital, Rikshospitalet, Oslo, Norway; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes, Paris, France (MFA); Department of Dermatology (EA) and Oncogenics Unit (EA, EF), Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv, Israel (EA); Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy (GBS, EFPG); Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital, Genoa, Italy (GBS, EFPG); Division of Cancer Epidemiology and Gene

View Article

Download full-text PDF

Source
https://genepi.qimr.edu.au/contents/p/staff/IlesMM_JNCI_EPUB
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/dju267
Publisher Site
http://dx.doi.org/10.1093/jnci/dju267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196080PMC
October 2014

Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data.

Hum Mol Genet 2014 Sep 11;23(17):4710-20. Epub 2014 Apr 11.

The Queensland Brain Institute and The University of Queensland Diamantina Institute, Brisbane, QLD, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddu174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119411PMC
September 2014

Advances in IBD genetics.

Nat Rev Gastroenterol Hepatol 2014 Jun 11;11(6):372-85. Epub 2014 Mar 11.

Gastrointestinal Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XU, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2014.27DOI Listing
June 2014

PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease.

Am J Gastroenterol 2014 Jun;109(6):925-7

1] Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2014.89DOI Listing
June 2014

Selenoprotein S is a marker but not a regulator of endoplasmic reticulum stress in intestinal epithelial cells.

Free Radic Biol Med 2014 Feb 22;67:265-77. Epub 2013 Nov 22.

Signal Transduction Laboratory, Queensland Institute of Medical Research, Herston, QLD 4006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.freeradbiomed.2013.11.001DOI Listing
February 2014

Crohn's disease and smoking: is it ever too late to quit?

J Crohns Colitis 2013 Dec 20;7(12):e665-71. Epub 2013 Jun 20.

Centre for Inflammatory Bowel Diseases, Fremantle Hospital, WA, Australia; University Department of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, WA, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.crohns.2013.05.007DOI Listing
December 2013

Hypoxia and Integrin-Mediated Epithelial Restitution during Mucosal Inflammation.

Front Immunol 2013 Sep 11;4:272. Epub 2013 Sep 11.

School of Biomedical Sciences and Pharmacy, University of Newcastle , Newcastle, NSW , Australia ; Hunter Medical Research Institute , New Lambton, NSW , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2013.00272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769679PMC
September 2013

Common PPARγ variants C161T and Pro12Ala are not associated with inflammatory bowel disease in an Australian cohort.

J Gastrointestin Liver Dis 2012 Dec;21(4):349-55

Inflammatory Bowel Diseases Laboratory, Queensland Institute of Medical Research, Herston, Australia.

View Article

Download full-text PDF

Source
December 2012

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:
Luke Jostins Stephan Ripke Rinse K Weersma Richard H Duerr Dermot P McGovern Ken Y Hui James C Lee L Philip Schumm Yashoda Sharma Carl A Anderson Jonah Essers Mitja Mitrovic Kaida Ning Isabelle Cleynen Emilie Theatre Sarah L Spain Soumya Raychaudhuri Philippe Goyette Zhi Wei Clara Abraham Jean-Paul Achkar Tariq Ahmad Leila Amininejad Ashwin N Ananthakrishnan Vibeke Andersen Jane M Andrews Leonard Baidoo Tobias Balschun Peter A Bampton Alain Bitton Gabrielle Boucher Stephan Brand Carsten Büning Ariella Cohain Sven Cichon Mauro D'Amato Dirk De Jong Kathy L Devaney Marla Dubinsky Cathryn Edwards David Ellinghaus Lynnette R Ferguson Denis Franchimont Karin Fransen Richard Gearry Michel Georges Christian Gieger Jürgen Glas Talin Haritunians Ailsa Hart Chris Hawkey Matija Hedl Xinli Hu Tom H Karlsen Limas Kupcinskas Subra Kugathasan Anna Latiano Debby Laukens Ian C Lawrance Charlie W Lees Edouard Louis Gillian Mahy John Mansfield Angharad R Morgan Craig Mowat William Newman Orazio Palmieri Cyriel Y Ponsioen Uros Potocnik Natalie J Prescott Miguel Regueiro Jerome I Rotter Richard K Russell Jeremy D Sanderson Miquel Sans Jack Satsangi Stefan Schreiber Lisa A Simms Jurgita Sventoraityte Stephan R Targan Kent D Taylor Mark Tremelling Hein W Verspaget Martine De Vos Cisca Wijmenga David C Wilson Juliane Winkelmann Ramnik J Xavier Sebastian Zeissig Bin Zhang Clarence K Zhang Hongyu Zhao Mark S Silverberg Vito Annese Hakon Hakonarson Steven R Brant Graham Radford-Smith Christopher G Mathew John D Rioux Eric E Schadt Mark J Daly Andre Franke Miles Parkes Severine Vermeire Jeffrey C Barrett Judy H Cho

Nature 2012 Nov;491(7422):119-24

Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1HH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature11582DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491803PMC
November 2012

Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold?

Gastroenterology 2012 May 24;142(5):e17; author reply e18. Epub 2012 Mar 24.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2012.02.054DOI Listing
May 2012

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

Authors:
Carl A Anderson Gabrielle Boucher Charlie W Lees Andre Franke Mauro D'Amato Kent D Taylor James C Lee Philippe Goyette Marcin Imielinski Anna Latiano Caroline Lagacé Regan Scott Leila Amininejad Suzannah Bumpstead Leonard Baidoo Robert N Baldassano Murray Barclay Theodore M Bayless Stephan Brand Carsten Büning Jean-Frédéric Colombel Lee A Denson Martine De Vos Marla Dubinsky Cathryn Edwards David Ellinghaus Rudolf S N Fehrmann James A B Floyd Timothy Florin Denis Franchimont Lude Franke Michel Georges Jürgen Glas Nicole L Glazer Stephen L Guthery Talin Haritunians Nicholas K Hayward Jean-Pierre Hugot Gilles Jobin Debby Laukens Ian Lawrance Marc Lémann Arie Levine Cecile Libioulle Edouard Louis Dermot P McGovern Monica Milla Grant W Montgomery Katherine I Morley Craig Mowat Aylwin Ng William Newman Roel A Ophoff Laura Papi Orazio Palmieri Laurent Peyrin-Biroulet Julián Panés Anne Phillips Natalie J Prescott Deborah D Proctor Rebecca Roberts Richard Russell Paul Rutgeerts Jeremy Sanderson Miquel Sans Philip Schumm Frank Seibold Yashoda Sharma Lisa A Simms Mark Seielstad A Hillary Steinhart Stephan R Targan Leonard H van den Berg Morten Vatn Hein Verspaget Thomas Walters Cisca Wijmenga David C Wilson Harm-Jan Westra Ramnik J Xavier Zhen Z Zhao Cyriel Y Ponsioen Vibeke Andersen Leif Torkvist Maria Gazouli Nicholas P Anagnou Tom H Karlsen Limas Kupcinskas Jurgita Sventoraityte John C Mansfield Subra Kugathasan Mark S Silverberg Jonas Halfvarson Jerome I Rotter Christopher G Mathew Anne M Griffiths Richard Gearry Tariq Ahmad Steven R Brant Mathias Chamaillard Jack Satsangi Judy H Cho Stefan Schreiber Mark J Daly Jeffrey C Barrett Miles Parkes Vito Annese Hakon Hakonarson Graham Radford-Smith Richard H Duerr Séverine Vermeire Rinse K Weersma John D Rioux

Nat Genet 2011 Mar 6;43(3):246-52. Epub 2011 Feb 6.

Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084597PMC
March 2011

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.

Nat Genet 2010 Dec;42(12):1118-25

Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, Kiel, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.717DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299551PMC
December 2010

Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.

J Gastroenterol Hepatol 2010 Nov;25(11):1732-8

The Centre for Inflammatory Bowel Diseases, Fremantle Hospital, University of Western Australia, Fremantle, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1746.2010.06407.xDOI Listing
November 2010

Anti-tumour necrosis factor-alpha treatment for perianal Crohn's disease in Australia.

Med J Aust 2010 Apr;192(7):375-7

Department of Gastroenterology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
April 2010

Role of diet in the development of inflammatory bowel disease.

Inflamm Bowel Dis 2010 Jan;16(1):137-51

Department of Nutrition and Dietetics, Royal Brisbane and Women's Hospital, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.20968DOI Listing
January 2010

The use of indigocarmine spray increases the colonoscopic detection rate of adenomas.

J Gastroenterol 2009 16;44(8):826-33. Epub 2009 May 16.

Department of Gastroenterology and Hepatology, Royal Brisbane and Women's Hospital, Level 9 Ned Hanlon Building, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-009-0065-3DOI Listing
October 2009

Body composition and muscle strength as predictors of bone mineral density in Crohn's disease.

J Bone Miner Metab 2009 31;27(4):456-63. Epub 2009 Mar 31.

School of Human Movement Studies, Faculty of Health Sciences, The University of Queensland, Brisbane, QLD, 4072, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00774-009-0059-5DOI Listing
September 2009

Intestinal barrier dysfunction in inflammatory bowel diseases.

Inflamm Bowel Dis 2009 Jan;15(1):100-13

Mucosal Diseases Program, Mater Medical Research Institute, University of Queensland, Aubigny Place, Mater Health Services, South Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.20539DOI Listing
January 2009

ACE inhibitors and angiotensin II receptor antagonists in Crohn's disease management.

Expert Rev Gastroenterol Hepatol 2008 Oct;2(5):645-51

Inflammatory Bowel Disease Laboratory, Royal Brisbane and Women's Research Foundation, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2.5.645DOI Listing
October 2008

Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population.

Inflamm Bowel Dis 2008 May;14(5):585-90

Inflammatory Bowel Disease Laboratory, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.20362DOI Listing
May 2008

The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability.

Hum Pathol 2008 Feb 24;39(2):243-50. Epub 2007 Oct 24.

Department of Medicine, National University of Ireland Cork, Clinical Science Building, Cork University Hospital, Wilton, Cork, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2007.06.010DOI Listing
February 2008

Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease.

J Gastroenterol Hepatol 2007 Aug 7;22(8):1306-12. Epub 2007 Jun 7.

Monash University Department of Medicine and Department of Gastroenterology, Box Hill Hospital, Box Hill, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1746.2007.04930.xDOI Listing
August 2007

Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.

J Gastroenterol Hepatol 2007 Jun;22(6):913-9

School of Human Movement Studies, University of Queensland, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1746.2006.04679.xDOI Listing
June 2007

How useful are biomarkers for the prediction of short-term relapse in patients with Crohn's disease?

Nat Clin Pract Gastroenterol Hepatol 2007 Feb;4(2):72-3

IBD Unit, Department of Gastroenterology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpgasthep0716DOI Listing
February 2007

Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease--Are we there yet?

World J Gastroenterol 2006 Nov;12(44):7097-103

IBD Unit, Department of Gastroenterology, Royal Brisbane and Womens Hospital, Brisbane, Queensland 4029, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087769PMC
http://dx.doi.org/10.3748/wjg.v12.i44.7097DOI Listing
November 2006

Clinically active Crohn's disease in the presence of a low C-reactive protein.

Scand J Gastroenterol 2006 Mar;41(3):306-11

Brisbane IBD Research Group, Department of Medicine and ECMB Laboratory, University of Queensland, Mater Medical Research Institute, South Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365520500217118DOI Listing
March 2006

Bone loss in Crohn's disease: exercise as a potential countermeasure.

Inflamm Bowel Dis 2005 Dec;11(12):1108-18

School of Human Movement Studies, The University of Queensland, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mib.0000192325.28168.08DOI Listing
December 2005

Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.

J Pathol 2003 Sep;201(1):46-54

Inflammatory Bowel Disease Laboratory, Royal Brisbane Hospital Foundation Clinical Research Centre, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1406DOI Listing
September 2003

The pathogenesis of Crohn's disease in the 21st century.

Pathology 2002 Dec;34(6):561-7

Department of Gastroenterology and Hepatology, Royal Brisbane Hospital, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
December 2002